Sufentanil Bispectral Index Elderly

• Status: Completed
• Trial end date: 2015-11-01
• Target enrollment: 0
• Participant gender: All

Summary

We compared BIS values during propofol stepwise induction with or without concomitant sufentanil in patients ≥ 65 years .

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Geneva
• Treatments: Propofol; Sufentanil

Criteria

Inclusion Criteria:

• Age ≥65 years

Exclusion Criteria:

• History of heart disease

• History of renal disease

• History of psychiatric

• Obesity

• Allergy to propofol or sufentanil